Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Gilead Sciences,Emtricitabine - tenofovir alafenamide,HIV 1,Emtricitabine - tenofovir alafenamide,Only if cost neutral or cost saving,,Infections - Agents for Systemic Use
